Research Paper Volume 16, Issue 1 pp 872—910
XRCC1: a potential prognostic and immunological biomarker in LGG based on systematic pan-cancer analysis
Figure 9. The relationship between XRCC1 expression and pan-cancer immune subtypes. (A) in BLCA, (B) in BRCA, (C) in COAD, (D) in ESCA, (E) in HNSC, (F) in KIRC, (G) in LGG, (H) in LIHC, (I) in LUAD, (J) in PAAD, (K) in PCPG, (L) in PRAD, (M) in SARC, (N) in STAD, (O) in TGCT, (P) in UCS.